The U.S. insulin pump market is projected to grow from USD 2.33 billion in 2025 to USD 4.67 billion by 2035, registering a CAGR of 7.20%, driven by rising diabetes prevalence, technological advancements, and increasing adoption of automated insulin delivery systems.

U.S. Insulin Pump Market Statical Scope

The market is mainly influenced by the growing number of diabetes cases, both Type 1 and Type 2, fast advancements in automated insulin delivery (AID) systems, and a strong demand from patients for more convenience than daily injections.

The market is essential due to the increasing diabetes rates, which require advanced, automated, and continuous insulin delivery options that enhance glycemic control and improve quality of life. The industry plays a vital role in incorporating artificial intelligence (AI), machine learning (ML), and smart technology into pumps, enabling real-time, personalized glucose monitoring and automatic dosage adjustments. Insulin pump s assist in keeping blood sugar levels stable, greatly lowering the risk of hypoglycemia compared to traditional daily injections. The U.S. market is at the forefront of adopting these technologies, making it a significant contributor to global advancements in diabetes care.

U.S. Insulin Pump Market Share, By Type, 2025 (%)

• Patch Pumps - Patch Pumps represent a notable segment, holding 42% of the market, due to the growing demand for discreet, wearable, and easy-to-use insulin delivery systems that improve patient comfort and mobility.
• Tethered Pumps - Tethered Pumps dominate the market with a 58% share, fueled by their proven clinical reliability, accurate insulin delivery control, and widespread use in both hospital and long-term diabetes care.

U.S. Insulin Pump Market Share, By Product, 2025 (%)

• MiniMed - MiniMed is a top player, capturing 25% of the market, bolstered by strong brand loyalty, advanced automation capabilities, and extensive clinical use in insulin pump therapy.
• Accu-Chek - Accu-Chek has an 8% market share, limited by tougher competition from newer, more sophisticated pump systems available.

U.S. Insulin Pump Market Share, By Accessories, 2025 (%)

• Insulin Reservoir/Cartridges - Insulin Reservoir/Cartridges lead the market with a 45% share, driven by their necessary ongoing use in insulin pump operations and steady replacement needs.
• Insulin Set Insertion Devices - Insulin Set Insertion Devices account for a significant 35% share, supported by the demand for effective and safe setup and maintenance of insulin delivery systems.

U.S. Insulin Pump Market Share, By End Use, 2025 (%)

• Hospitals & Clinics - Hospitals & Clinics command a substantial 38% share, backed by strong adoption in clinical oversight, patient onboarding, and short-term intensive diabetes management.
• Homecare - Homecare leads the segment with a 57% share, driven by a growing preference for self-managed diabetes care and the ease of administering insulin at home.

Top Companies in the U.S. Insulin Pump Market

• Medtronic
• Hoffmann-La Roche AG
• Tandem Diabetes Care, Inc.
• Insulet Corporation
• Ypsomed
• Sanofi S.A.
• Sooil development
• Jiangsu Delfu Co., Ltd.
• Cellnovo Ltd
• Valeritas, Inc

Segments Covered in the Report

By Type

• Patch pumps
• Tethered pumps

By Product

• MiniMed
• Accu-Chek
• Tandem
• Omnipod
• My life omnipod
• Others

By Accessories

• Insulin reservoir or cartridges
• Insulin set insertion devices
• Battery

By End User

• Hospitals & clinics
• Homecare
• Laboratories